Trial access to CAS BioFinder Discovery Platform™ until 31 December 2025

The WMU Library invites you to take advantage of trial access to the CAS BioFinder Discovery Platform™ database – a new tool supporting the process of drug discovery and optimisation.

CAS BioFinder™ enables:

• centralisation and integration of data from scientific literature, patents and journals,
• rapid search and analysis of bioactivity information,
• visual exploration of links between diseases, modalities, target proteins and biomarkers,
• prediction of the activity of new chemical compounds and potential interactions.

The database thus supports the identification of key connections and the optimisation of compounds, accelerating the research process and the development of innovative therapies.

Registration for first-time users

Trial access from 15 October to 31 December 2025.
For whom: all academic users with access to SciFinder.